Insmed to host fourth-quarter and full-year 2024 financial results conference call on thursday, february 20, 2025

Bridgewater, n.j. , feb. 10, 2025 /prnewswire/ -- insmed incorporated (nasdaq: insm), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its fourth-quarter and full-year 2024 financial results on thursday, february 20, 2025.
INSM Ratings Summary
INSM Quant Ranking